Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon 1Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon 1Q

Operating income was $3.9 million in the quarter, compared to a loss of $4.0 million in 1Q08. Gross profit was up 19% to $30.7 million due to improved cost structure, favorable foreign exchange impact and lower inventory provisions, offsetting lower reven

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 1Q

1Q Revenues: $147.2 million (-10%)

1Q Loss: $6.0 million (loss of $15.0 million 1Q08)

Comments: Operating income was $3.9 million in the quarter, compared to a loss of $4.0 million in 1Q08. Gross profit was up 19% to $30.7 million due to improved cost structure, favorable foreign exchange impact and lower inventory provisions, offsetting lower revenues. Commercial manufacturing revenues from operations decreased 12%, or $16.2 million. Revenues from North American operations were down 16% to $55.3 million due to lower customer demand from the Cincinnati and Whitby operations, partially offset by higher revenue in Puerto Rico. Revenues from European operations decreased $6.0 million or 9% compared to prior year. Pharmaceutical Development Services revenues were down 2% to $29.5 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters